This product is not intended to diagnose, treat, cure, or prevent any diseases
Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
10.1016/j.bbapap.2012.09.014 Biochim
Guaranteed or its free.* Target 34+ symptoms, including: Hot flashes, night sweats, and disrupted sleep Low energy, weight changes, and joint or hip pain Vaginal dryness, urinary symptoms, and low libido from $65.99/month Targeted hormone care, personalized to your symptoms